Prospective Research on the Intervention of Myoless2.0 in Europe (PRIME)

by palligoelme@gmail.com | Feb 6, 2026 | Clinical Trials

​ Conditions: Myopia Progression Interventions: Other: myopia control lens Sponsors: Indizen Optical Technologies, S.L.U.; Hospital San Carlos, Madrid; University of Minho; University of Ulster Not yet recruiting Conditions: Myopia Progression Interventions: Other:...

Neo-Adjuvant Endocrine Therapy in Post-Menopausal Hormone Receptor Positive HER 2 Neu Negative Node Positive Early-Stage Breast Cancer Patients With One Year of Letrozole.

by palligoelme@gmail.com | Feb 6, 2026 | Clinical Trials

​ Conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer Interventions: Drug: Letrozole Sponsors: Cancer Care Hospital & Research Centre Foundation, Lahore Not yet recruiting Conditions: Hormone Receptor-Positive, HER2-Negative, Node...

Age Related Chromatin Remodelling as a Therapeutic Target for Organ Protection in Cardiac Surgery

by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials

​ Conditions: Cardiac Surgery; Organ Protection; Ageing Interventions: Other: other Sponsors: University of Leicester Active, not recruiting Conditions: Cardiac Surgery; Organ Protection; Ageing Interventions: Other: other Sponsors: University of Leicester Active, not...

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials

​ Conditions: HIV (Human Immunodeficiency Virus); HPV; Cervical Precancer Interventions: Procedure: Thermal ablation (TA) with 1 probe; Procedure: Thermal ablation (TA) with 2 probes Sponsors: Fred Hutchinson Cancer Center; University of Washington; National Cancer...

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials

​ Conditions: Glioblastoma; High-Grade Glioma (WHO III-IV); High-grade Glioma; Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Hemispheric Glioma, H3G34 Mutant Interventions: Drug: ADI-PEG 20 (Arginine deiminase pegylated); Drug: Temozolomide (TMZ); Radiation:...